Abstract
Breast cancer is increasing at an alarming rate in women around the world, where medical biology is confronted by this disease on two crucial fronts. The first step is the early accurate diagnosis, which is very critical and the second step involves the appropriate clinical management. The current trend in molecular imaging of breast cancer provides not only an excellent tool in diagnosing the disease but also useful in validating the potentiality of pharmaceutical interventions. This review addresses the effectiveness of targeted imaging technologies to resolve the molecular characterisation and pathological evidences in breast cancer. The focus is on the present practices in breast cancer imaging, specifically targeting cellular machineries such as hormone receptors and angiogenic factors.
Keywords: Molecular imaging, breast cancer, hormones, estrogen receptor, molecular therapy, estradiol, early accurate diagnosis, appropriate clinical management, pharmaceutical interventions, cellular machineries, angiogenic factors, availability of screening tools, of screening tools, adjuvant therapy, Hormonal therapy
Current Pharmaceutical Biotechnology
Title: Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy
Volume: 12 Issue: 4
Author(s): Parasuraman Padmanabhan, Julian Goggi, Romain Bejot and Kishore K. Bhakoo
Affiliation:
Keywords: Molecular imaging, breast cancer, hormones, estrogen receptor, molecular therapy, estradiol, early accurate diagnosis, appropriate clinical management, pharmaceutical interventions, cellular machineries, angiogenic factors, availability of screening tools, of screening tools, adjuvant therapy, Hormonal therapy
Abstract: Breast cancer is increasing at an alarming rate in women around the world, where medical biology is confronted by this disease on two crucial fronts. The first step is the early accurate diagnosis, which is very critical and the second step involves the appropriate clinical management. The current trend in molecular imaging of breast cancer provides not only an excellent tool in diagnosing the disease but also useful in validating the potentiality of pharmaceutical interventions. This review addresses the effectiveness of targeted imaging technologies to resolve the molecular characterisation and pathological evidences in breast cancer. The focus is on the present practices in breast cancer imaging, specifically targeting cellular machineries such as hormone receptors and angiogenic factors.
Export Options
About this article
Cite this article as:
Padmanabhan Parasuraman, Goggi Julian, Bejot Romain and K. Bhakoo Kishore, Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy, Current Pharmaceutical Biotechnology 2011; 12 (4) . https://dx.doi.org/10.2174/138920111795163959
DOI https://dx.doi.org/10.2174/138920111795163959 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs
Current Pharmaceutical Biotechnology HIF-1α and Calcium Signaling as Targets for Treatment of Prostate Cancer by Cardiac Glycosides
Current Cancer Drug Targets Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Current Pharmaceutical Design The Role of Snail in EMT and Tumorigenesis
Current Cancer Drug Targets Targeting ADAM17 Sheddase Activity in Cancer
Current Drug Targets TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Current Drug Safety Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry The Anti-Inflammatory and Pharmacological Actions of Oleocanthal, a Phenolic Contained in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Current Pharmaceutical Biotechnology Novel Insights into Targeting ATP-Binding Cassette Transporters for Antitumor Therapy
Current Medicinal Chemistry Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs)
Current Medicinal Chemistry FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver
Current Stem Cell Research & Therapy Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis
Current Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
Current Pharmaceutical Biotechnology Novobiocin Analogs as Potential Anticancer Agents
Mini-Reviews in Medicinal Chemistry